Phathom Pharmaceuticals, Inc. (PHAT)
14.69
+0.13
(+0.89%)
USD |
NASDAQ |
Dec 15, 16:00
14.95
+0.26
(+1.77%)
Pre-Market: 09:22
Phathom Pharmaceuticals EPS Diluted (Quarterly): -0.4084 for Sept. 30, 2025
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Vistagen Therapeutics, Inc. | -0.5432 |
| NovaBay Pharmaceuticals, Inc. | -0.22 |
| Palatin Technologies, Inc. | 4.258 |
| Theriva Biologics, Inc. | -0.4507 |
| Oragenics, Inc. | -1.965 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -29.97M |
| Revenue (Quarterly) | 49.50M |
| Total Expenses (Quarterly) | 79.48M |
| Enterprise Value | 1.493B |
| Gross Profit Margin (Quarterly) | 87.50% |
| Profit Margin (Quarterly) | -60.55% |
| Earnings Yield | -25.96% |
| Normalized Earnings Yield | -25.96 |